COLTS NECK, NJ, July 17, 2012 – Nextremity Solutions, Inc. announced it has reached the 1000th NEXTRA Hammertoe Correction System worldwide. The company has also initiated a multi-center, post-market clinical study in the United States. The clinical study will provide data on the patient safety, performance and benefits of the fully adjustable and reversible NEXTRA Hammertoe Correction System. The study has the participation of nine prestigious surgery centers, which have started enrolling patients.
Dr. Lon Weiner, MD, Company Co-founder, commented, “We are happy to have achieved such an important milestone so quickly in the Company’s development. We expect the data from the study will confirm the early positive outcomes and provide compelling data that the Nextra implant will lead to an improved quality of life for the millions of people who suffer from hammertoes.”
About Nextremity Solutions, Inc.
Nextremity Solutions is a privately held medical-device company offering a novel approach to the surgical correction of small bone deformity, degeneration and trauma, founded by surgeons who are committed to the development of medical implants that will provide repeatable and superior patient outcomes.
Nextra™ Hammertoe Correction System and Nextra™ Hammertoe Correction Implant are trademarks of Nextremity Solutions, Inc.
For further information, visit www.nextremitysolutions.com or call 574-635-3023.